A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Stopped early · Phase 3

Conditions studied: Migraine

In brief

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.

Key facts

Study ID

NCT04396574

Run by

Eli Lilly and Company

People needed

558

Starts

2020-06-30

Expected to finish

2025-12-04

Last updated by the study team

2026-06-25

Who can join

Age: 6 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants must have completed study H8H-MC-LAHX (NCT03988088) or study H8H-MC-LAHV (NCT number to be determined)
• Participants must weigh at least 15 kilograms (kg)

You may not qualify if…

• Participants must not be pregnant or nursing
• Participants must not have any acute, serious, or unstable medical condition
• Participants must not be actively suicidal or at significant risk for suicide, in the opinion of the investigator

Where it is running

• Rehabilitation & Neurological Services — Huntsville, Alabama, United States
• Phoenix Children's Hospital — Phoenix, Arizona, United States
• Perseverance Research Center — Scottsdale, Arizona, United States
• Center for Neurosciences — Tucson, Arizona, United States
• Arkansas Children's — Little Rock, Arkansas, United States
• Core Healthcare Group — Cerritos, California, United States
• Miller Children's & Women's Hospital Long Beach — Long Beach, California, United States
• Sensa Health — Los Angeles, California, United States
• Orange County Research Institute - Ontario — Ontario, California, United States
• Yale University School of Medicine — New Haven, Connecticut, United States
• Children's National Medical Center — Washington D.C., District of Columbia, United States
• Wolfson Children's Hospital — Jacksonville, Florida, United States
• Clinical Neuroscience Solutions, Inc. dba CNS Healthcare — Jacksonville, Florida, United States
• Biotech Pharmaceutical Group — Miami, Florida, United States
• New Horizon Research Center — Miami, Florida, United States
• Ezy Medical Research — Miami Lakes, Florida, United States
• Suncoast Clinical Research, Inc. — New Port Richey, Florida, United States
• Avanza Medical Research Center — Pensacola, Florida, United States
• Clinical Research Center of Florida — Pompano Beach, Florida, United States
• USF Health — Tampa, Florida, United States
• ForCare Clinical Research — Tampa, Florida, United States
• Palm Beach Neurology — West Palm Beach, Florida, United States
• Pediatric Neurology P.A. — Winter Park, Florida, United States
• Meridian Clinical Research, LLC — Savannah, Georgia, United States
• Central Research Associates — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.